Mitophagy, by maintaining mitochondrial quality control, plays a key role in maintaining kidney function and is impaired in pathologic states. Macrophages are well known for their pathogenic role in kidney fibrosis. Here, we report that PINK1/Parkin-mediated mitophagy in macrophages is compromised in experimental and human kidney fibrosis. We demonstrate downregulation of mitophagy regulators mitofusin-2 (MFN2) and Parkin downstream of PINK1 in kidney fibrosis. Loss of either Pink1 or Prkn promoted renal extracellular matrix accumulation and frequency of profibrotic/M2 macrophages. Pink1 -/or Prkn -/-BM-derived macrophages (BMDMs) showed enhanced expression of rictor. Mitochondria from TGF-b1treated Pink1 -/-BMDMs exhibited increased superoxide levels, along with reduced respiration and ATP production. In addition, mitophagy in macrophages involves PINK1mediated phosphorylation of downstream MFN2, MFN2-facilitated recruitment of Parkin to damaged mitochondria, and macrophage-specific deletion of Mfn2 aggravates kidney fibrosis. Moreover, mitophagy regulators were downregulated in human CKD kidney and TGF-b1-treated human renal macrophages, whereas Mdivi1 treatment suppressed mitophagy mediators and promoted fibrotic response. Taken together, our study is the first to our knowledge to demonstrate that macrophage mitophagy plays a protective role against kidney fibrosis via regulating the PINK1/MFN2/Parkin-mediated pathway.
Introduction
Macrophages play an integral role in inflammation and subsequent progression of kidney fibrosis, a common manifestation of chronic kidney disease (CKD) (1) . Macrophage depletion in experimental models of kidney fibrosis such as unilateral ureteral obstruction (UUO) results in dramatically reduced interstitial fibrosis (2) . Following kidney injury, tubular cell-derived chemokines, including C-C motif chemokine ligand 2 (CCL2), promote the infiltration of C-C chemokine receptor type 2 (CCR2) expressing Ly6C hi /proinflammatory monocytes that express markers of M1/classically activated macrophages into the kidney (3, 4) . The inflammatory renal microenvironment favors the switch-over of Ly6C hi / proinflammatory or M1 population to Ly6C lo /antiinflammatory phenotype, which exhibits a profibrotic transcriptional profile and may contribute to M2 macrophages (5, 6) .
Persistent kidney injury and inflammation result in the failure of tissue repair, mitochondrial dysfunction, and tubular apoptosis (1, 6, 7) . Chronic unresolved inflammation also promotes switchover of proinflammatory macrophages into antiinflammatory or M2 phenotype (7) , which results in increased TGF-β1 production (8) . TGF-β1, a pluripotent multifunctional and a key profibrogenic cytokine, favors the transdifferentiation of M2 macrophages into myofibroblasts (7, 8) . Monocyte/ macrophage-specific deletion of TGF-β receptor II has been shown to significantly reduce the infiltration of macrophages and tubulointerstitial fibrosis (9) . However, macrophage-specific TGF-β1 deletion failed to prevent kidney fibrosis (10, 11) . Despite the increasing attention on the role of macrophages in kidney fibrosis, the mechanism of macrophage-induced extracellular matrix (ECM) remodeling is poorly understood.
Mitophagy, by maintaining mitochondrial quality control, plays a key role in maintaining kidney function and is impaired in pathologic states. Macrophages are well known for their pathogenic role in kidney fibrosis. Here, we report that PINK1/Parkin-mediated mitophagy in macrophages is compromised in experimental and human kidney fibrosis. We demonstrate downregulation of mitophagy regulators mitofusin-2 (MFN2) and Parkin downstream of PINK1 in kidney fibrosis. Loss of either Pink1 or Prkn promoted renal extracellular matrix accumulation and frequency of profibrotic/M2 macrophages. Pink1 -/or Prkn -/-BM-derived macrophages (BMDMs) showed enhanced expression of rictor. Mitochondria from TGF-β1-treated Pink1 -/-BMDMs exhibited increased superoxide levels, along with reduced respiration and ATP production. In addition, mitophagy in macrophages involves PINK1-mediated phosphorylation of downstream MFN2, MFN2-facilitated recruitment of Parkin to damaged mitochondria, and macrophage-specific deletion of Mfn2 aggravates kidney fibrosis. Moreover, mitophagy regulators were downregulated in human CKD kidney and TGF-β1-treated human renal macrophages, whereas Mdivi1 treatment suppressed mitophagy mediators and promoted fibrotic response. Taken together, our study is the first to our knowledge to demonstrate that macrophage mitophagy plays a protective role against kidney fibrosis via regulating the PINK1/MFN2/Parkin-mediated pathway. (A) Western blot and densitometry analysis for expression of Mitofusin 2 (MFN2), Parkin, and microtubule-associated protein light chain 3 (LC3) normalized to β-actin in kidney tissue lysates from WT mice 7 days after sham or UUO surgery. Data are mean ± SEM representative of 3 independent experiments (n = 3 per group) and analyzed by Student's unpaired 2-tailed t test. (B) Representative Masson's trichrome-stained kidney tissue sections (×40 magnification) from WT, Pink1 -/-, and Prkn -/mice 7 days after sham (n = 3 per group) or UUO (n = 5 per group) surgery. Ten areas from random fields per experimental group were analyzed and quantitated using ImageJ. Data are mean ± SEM, compared using 1-way ANOVA. Scale bars: 200 μm. (C and D) Western blot and densitometry analysis for the expression of fibronectin (FN), TGF-β1, and arginase I (Arg-I) normalized to GAPDH in kidney tissue lysates from Pink1 +/+ and Pink1 -/-(C), as well as Prkn +/+ and Prkn -/-(D), mice 7 days after sham or UUO surgery. Data are mean ± SEM representative of 3 independent experiments (n = 3 per group) and analyzed by 1-way ANOVA. *P < 0.05, **P < 0.01, ***P < 0.001. fibronectin (FN, 220 kDa), TGF-β1 (cleaved, 12.5 kDa), and M2/profibrotic macrophage marker arginase I (Arg-I, 35 kDa) after UUO than Pink1 +/+ ( Figure 1C ) and Prkn +/+ ( Figure 1D ) mice.
Using an AD model of kidney fibrosis, we confirmed that Pink1 -/mice fed with AD (28 days) compared with Pink1 +/+ AD-fed mice displayed higher kidney collagen content, as confirmed by quantitation of hydroxyproline content (Supplemental Figure 1B) , and lower kidney weight (Supplemental Figure 1C ), suggesting higher renal damage since the kidney weight negatively correlates with the degree of kidney damage (23) . Circulating levels of CCL2 (also known as monocyte chemoattractant protein-1; MCP-1) are directly related to the monocyte infiltration, inflammation, and tubulointerstitial fibrosis (24) , and AD-fed Pink1 -/mice displayed higher plasma levels of CCL2 than AD-fed Pink1 +/+ mice (Supplemental Figure  1D ), suggesting higher monocyte recruitment into the damaged kidney. Further, we observed that the kidneys from AD-fed Prkn -/mice also displayed higher expression of FN, collagen-I (Col-I, 115 kDa), and profibrotic macrophage markers CD206 (190 kDa) and galectin-3 (Gal-3) compared with AD-fed Prkn +/+ mice (Supplemental Figure 1E ). In addition, we demonstrated that the counts of Gal-3 + F4/80 + renal macrophages and TGF-β1 + F4/80 + renal macrophages were increased in the kidneys of mice fed with AD (28 days) compared with control diet, as assessed by flow cytometry analysis of renal single-cell suspensions and gated on CD45 + side scatter low (SSC lo ) mononuclear cells (Supplemental Figure 1 , F and G). We further confirmed that the Gal-3 + F4/80 + renal macrophages were higher in the AD-fed Pink1 -/and Prkn -/mice compared with the AD-fed Pink1 +/+ and Prkn +/+ mice, respectively.
Taken together, the above findings from 2 independent experimental models of CKD suggest that PINK1 and Parkin exert protective functions against kidney fibrosis.
PINK1 or Parkin deficiency amplifies frequency of renal profibrotic macrophages. To further investigate the involvement of PINK1 in modulating macrophage-derived fibrotic response during kidney fibrosis, we first determined the frequency of circulating and renal monocyte/macrophage populations after UUO. We compared the numbers of total mononuclear (CD45 + SSC lo ) and phagocytic (F4/80 + CD45 + ) populations and found similar increases in the absolute counts of both total mononuclear (Supplemental Figure  2A ) and mononuclear phagocytic (Supplemental Figure 2B ) cells in the obstructed kidneys from Pink1 +/+ and Pink1 -/mice after UUO. The absolute numbers of profibrotic/M2 macrophages were determined by gating on CD206 + F4/80 + cells. The profibrotic/M2 macrophages in the kidneys also increased after UUO; however, the obstructed kidneys from Pink1 -/mice had significantly higher numbers of profibrotic/M2 macrophages than Pink1 +/+ mice (Figure 2A ).
The differential expression of Ly6C is related to specific monocyte phenotype (5, (25) (26) (27) . Based on its differential expression, we gated 3 populations of CD11b expressing Ly6C hi , Ly6C int , and Ly6C lo monocytes. The counts of proinflammatory (Ly6C hi CD11b + ) monocytes in the kidneys after UUO increased in the Pink1 +/+ mice ( Figure 2B ). However, compared with Pink1 +/+ mice, Pink1 -/mice exhibited a lower frequency of the proinflammatory monocytes in the kidney. The frequency of Ly6C int CD11b + population, which is known to play reparative functions after kidney injury (25) , was lower in the kidneys of Pink1 -/than Pink1 +/+ mice. Moreover, the obstructed kidneys from Pink1 -/mice also had higher numbers of the Ly6C lo CD11b + monocytes compared with Pink1 +/+ mice ( Figure 2B ). Lower frequency of Ly6C hi and higher numbers of Ly6C lo phenotype in the obstructed kidneys from Pink1 -/mice suggest a potential switchover of Ly6C hi to Ly6C lo phenotype. There was no difference in the frequency of circulating proinflammatory (Ly6C hi CD11b + ) monocytes between Pink1 +/+ and Pink1 -/mice after UUO (Supplemental Figure 2C ). However, the numbers of circulating Ly6C lo CD11b + monocytes after UUO were higher in Pink1 -/mice (Supplemental Figure 2D ). The Ly6C lo CD11b + monocytes exhibit profibrotic transcriptional profile and favor the progression of kidney fibrosis through paracrine signaling (25) (26) (27) , which could at least in part account for the higher numbers of the profibrotic/M2 macrophages in the fibrotic kidney of Pink1 -/mice.
We next sorted the renal macrophages after sham or UUO surgery. The Pink1 -/renal macrophages after UUO showed significantly higher expression of FN, indicating higher profibrotic macrophage expression in case of PINK1 deficiency ( Figure 2C ).
We further examined whether genetic deficiency of Pink1 could exaggerate TGF-β1-induced fibrotic response by macrophages. In response to TGF-β1 treatment, Pink1 -/-BM-derived macrophages (BMDMs) displayed higher expression of profibrotic markers, including FN, Arg-I, and Gal-3 (26 kDa) ( Figure 2D ). These observations confirm that PINK1 suppresses the macrophage-induced fibrotic response.
We next investigated the effect of loss of Parkin on the expression of profibrotic/M2 macrophages and Ly6C monocyte populations after UUO. Consistent with the findings in Pink1 -/mice, the increase in the absolute counts of profibrotic/M2 macrophages in the kidney 7 days after UUO was higher in Prkn -/mice than Prkn +/+ mice ( Figure 3A ). The obstructed kidneys from Prkn -/mice showed lower frequencies of both Ly6C hi CD11b + and Ly6C int CD11b + populations than Prkn +/+ mice ( Figure 3B ). There were no differences in the UUO-induced increase in the numbers of total mononuclear (Supplemental Figure 3A ) and mononuclear phagocytic (Supplemental Figure 3B ) populations in the kidney and circulating Ly6C hi (Supplemental Figure 3C ) monocytes between Prkn +/+ and Prkn -/mice. However, the frequencies of Ly6C lo CD11b + monocytes in the kidney ( Figure 3B ) and circulating Ly6C lo monocytes in the blood (Supplemental Figure 3D ) after 7 days of UUO were higher in Prkn -/mice compared with Prkn +/+ mice. These results provide evidence that Parkin, downstream of PINK1, also prevents macrophage-derived fibrotic response in the kidney.
To understand the role of PINK1/Parkin-mediated mitophagy in macrophage polarization, we further induced the differentiation of BMDMs toward M0, M1, or M2 phenotypes in the presence of their respective inducers. Both Pink1 -/and Prkn -/-BMDMs displayed greater ability to polarize toward the profibrotic/M2 phenotype ( Figure 3C ), as confirmed by higher expression of Arg-I and rictor (200 kDa). In addition, both Pink1 -/and Prkn -/-CD11b + monocytes and F4/80 + macrophages isolated from peritoneal cavity also showed higher expression of rictor ( Figure 3D ). The increase in the expression of rictor is known to play a critical role in the differentiation of M2 macrophages (28, 29) . In contrast, loss of either PINK1 or Parkin did not affect the expression of inducible nitric oxide synthase-expressing (iNOS-expressing; 130 kDa) M1 macrophages. These findings indicate that the deficiency of either PINK1 or Parkin favors reprogramming of macrophages toward profibrotic/M2 phenotype.
Myeloid-specific deletion of Mfn2 exaggerates kidney fibrosis. To elucidate the macrophage-specific role of mitophagy in the progression of kidney fibrosis, we used LysM-Cre +/− Mfn2 fl/fl mice, in which Cre recombinase activity was induced under myeloid-specific promoter lysozyme M (LysM). We observed that the kidneys from AD-fed LysM-Cre +/− Mfn2 fl/fl mice displayed higher expression of FN, CD206, TGF-β1, and Gal-3 compared with their respective control (LysM-Cre −/− Mfn2 fl/fl ) mice ( Figure 4A ). Even the basal level of FN expression in the kidney was higher in LysM-Cre +/− Mfn2 fl/fl mice. AD-fed LysM-Cre +/− Mfn2 fl/fl mice also displayed higher collagen deposition and frequency of the Ly6C lo CD11b + monocytes in the kidneys compared with LysM-Cre −/− Mfn2 fl/fl mice, as assessed by Masson's trichrome staining ( Figure 4B ) and flow cytometry ( Figure 4C ), respectively. These findings indicate that macrophage-specific deletion of mitophagy regulator Mfn2 aggravates kidney fibrosis and suggest a critical role of macrophage mitophagy in protection against kidney fibrosis.
PINK1-mediated mitophagy is suppressed in renal macrophages after UUO and in TGF-β1-treated macrophages. To investigate the role of the mitophagy in macrophages, we first determined the effect of TGF-β1 treatment on PINK1 expression in THP-1-derived human macrophages. In our earlier studies, the detection of PINK1 expression in murine cells and tissues was limited due to lack of a reliable commercially available mouse-specific anti-PINK1 antibody. Using THP-1-derived human macrophages, we confirmed that PINK1 expression significantly decreased after TGF-β1 treatment ( Figure 5A ). We next sorted the renal macrophages from WT mice after sham or UUO surgery (Supplemental Figure  4A ) and determined that the expression of MFN2 and Parkin was significantly reduced in the macrophages isolated from the fibrotic kidney after UUO ( Figure 5B ).
We next determined the effect of TGF-β1 on the recruitment of the mitophagy regulatory proteins to the mitochondria of macrophages. We isolated the mitochondrial fractions from the BMDMs cultured in the presence or absence of TGF-β1 for 48 hours. TIM23 (a mitochondrial protein) and β-actin (a cytosolic marker) were used to confirm the purity of mitochondrial fractions. The expression of MFN2 and Parkin was significantly reduced in the mitochondrial lysates after TGF-β1 treatment ( Figure 5C ). Furthermore, confocal microscopy revealed that the colocalization of MitoTracker red dye-stained mitochondria with autophagosome-specific marker LC3 was decreased in BMDMs after TGF-β1 treatment ( Figure 5 , D and E). Pink1 -/-BMDMs displayed lower mitochondrial colocalization with LC3 than Pink1 +/+ BMDMs. We further performed the quantitative analysis of mitophagy via flow cytometry using renal single-cell suspensions isolated from kidneys of Pink1 +/+ and Pink1 -/mice fed with control or AD for 28 days. The mitophagy in macrophages was assessed by flow cytometry staining and by determining the median fluorescence intensity (MFI) of MitoTracker and LysoTracker dyes on F4/80 + cells. The mitophagy as assessed by MFI was lower in F4/80 + Pink1 +/+ renal macrophages after AD and in F4/80 + Pink1 -/renal macrophages ( Figure 5F ). These data indicate that macrophage mitophagy is reduced in AD-induced kidney fibrosis and in Pink1-deficient renal macrophages. We observed similar results in Pink1 -/-BMDMs.
The mitophagy in BMDMs was detected by quantifying double-positive signals, confirming the fusion and colocalization of Mtphagy dye-stained mitochondria with Lyso dye-labeled lysosome. The mitophagy in BMDMs was reduced after TGF-β1 treatment, and compared with Pink1 +/+ BMDMs, Pink1 -/-BMDMs displayed significantly reduced mitophagy ( Figure 5 , G and H) at the basal level. The above findings indicate that the mitophagy in macrophages is impaired under fibrotic conditions. MFN2 is phosphorylated by PINK1 and promotes Parkin recruitment to mitochondria in macrophage mitophagy. PINK1 is a mitochondrial serine/threonine kinase capable of phosphorylating specific mitochondrial proteins, including MFN2 (20) . We observed that knockdown of PINK1 expression in THP-1-derived human macrophages using PINK1-specific siRNA resulted in decreased expression of phosphorylated MFN2 at serine-442 (Ser-442, 86 kDa), relative to nontargeting control siRNA transfected macrophages ( Figure 6A ). TGF-β1 treatment also reduced the expression of PINK1 (precursor or full length, 64 kDa) in THP-1derived human macrophages. These findings suggest that MFN2 is a downstream mitochondrial protein target substrate of PINK1 in macrophages.
We further observed that the LysM-Cre +/− Mfn2 fl/fl BMDMs from myeloid Mfn2-conditional KO mice displayed significantly lower mitophagy with or without TGF-β1 treatment, compared with the corresponding control LysM-Cre −/− Mfn2 fl/fl BMDMs ( Figure 6 , B and C). These results indicate that MFN2 plays a critical functions in the regulation of mitophagy in macrophages. PINK1-dependent recruitment of Parkin to mitochondria has been shown to promote mitophagy (30, 31) . Thus, we investigated the role of MFN2 in the recruitment of Parkin to the mitochondria of macrophages. We isolated the mitochondrial fractions from the peritoneal macrophages cultured in the presence of DMSO (vehicle control) or carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP) (5 μM/mL) for 2 hours and analyzed for expression of Parkin and mitochondrial marker TOM20. Mitochondrial uncoupler FCCP induced recruitment of Parkin to the depolarized mitochondria, as confirmed in LysM-Cre −/− Mfn2 fl/fl macrophages ( Figure 6D ). However, in LysM-Cre +/− Mfn2 fl/fl macrophages, the FCCP-induced recruitment of Parkin to the mitochondria was considerably lower compared with LysM-Cre −/− Mfn2 fl/fl macrophages. These findings suggest that MFN2 may function upstream of Parkin and that, following PINK1-dependent activation of mitophagy, MFN2 promotes the recruitment of Parkin to the mitochondria in macrophages.
PINK1 deficiency impairs macrophage mitochondrial homeostasis during kidney fibrosis. To further examine the role of TGF-β1-mediated suppression of the expression of mitophagy regulators in macrophages, we studied the effects of TGF-β1 on macrophage mitochondrial respiration as assessed by Mito Stress test. We show that the macrophage mitochondrial respiration was decreased after treatment with TGF-β1. Pink1 -/-BMDMs after TGF-β1 treatment displayed significantly lower mitochondrial oxygen consumption rate (OCR), ATP production, spare respiratory capacity, and maximal respiration than Pink1 +/+ BMDMs ( Figure 7A ). There were no differences in the rate of nonmitochondrial respiration between Pink1 +/+ and Pink1 -/-BMDMs. TGF-β1-treated Pink1 -/-BMDMs exhibited higher production of mitochondrial-derived superoxide ions as measured by MitoSox staining ( Figure 7B ). These data suggest that TGF-β1 negatively affects macrophage mitochondrial homeostasis and that PINK1 deficiency further impairs the macrophage mitochondrial metabolic health.
We next studied the impact of the loss of PINK1-dependent mitophagy on the renal macrophage mitochondrial injury in experimental kidney fibrosis. We used transmission electron microscopy to analyze the ultrastructure of the renal macrophage mitochondria in the kidneys from Pink1 +/+ and Pink1 -/mice after 28 days of AD or control diet. Evidence of mitochondrial swelling in the renal macrophages was observed in Pink1 +/+ mice after AD-induced fibrosis. Renal macrophages from Pink1 -/mice fed with control diet displayed widening of the mitochondrial cristae. However, renal macrophages from AD-fed Pink1 -/mice had higher numbers of abnormal mitochondria, with evidence of reduced density of matrix and disorganized cristae, compared with Pink1 +/+ AD-fed mice ( Figure 7C ). These data suggest that lack of PINK1-mediated mitophagy-dependent elimination of damaged mitochondria contributes to their accumulation. Collectively, the above findings provide evidence that PINK1 exerts a critical role in maintaining renal macrophage mitochondrial quality control, and its deficiency contributes to macrophage mitochondrial injury during kidney fibrosis.
Mitophagy regulators PINK1, MFN2, and Parkin are repressed in the kidney and in circulating mononuclear cells from patients with CKD. Increased macrophage infiltration (32) and mitochondrial impairment (33) have been reported in patients with kidney diseases. Here, we explored the role of mitophagy in human kidney disease. Kidney allograft biopsy samples obtained from CKD patients with histological evidence of interstitial fibrosis and tubular atrophy (IFTA) ( Table 1 ) displayed significantly lower mRNA expression of mitophagy regulators PINK1 ( Figure 8A ), MFN2 ( Figure 8B ), and PRKN ( Figure 8C ), compared with kidney biopsy samples from patients with no CKD (CKD -). Furthermore, circulating levels of chemokine CCL2 were higher in the plasma samples from CKD patients ( Figure 8D ). CCL2 acts as a ligand for CCR2-expressing macrophages, and increased levels are known to promote macrophage infiltration (34) and progressive tubulointerstitial kidney disease (35) . Our findings suggest that, in CKD, mitophagy is suppressed, while increased circulating CCL2 induces macrophage infiltration to promote kidney fibrosis.
Similarly, peripheral blood mononuclear cells (PBMCs) from patients with severe CKD displayed lower expression of MFN2 ( Figure 8E ) and Parkin ( Figure 8F) , and higher mitochondrial-derived superoxide production ( Figure 8G ), than patients with mild or moderate CKD ( Table 2 ). Higher mROS levels and MitoTracker (red) dye, anti-LC3 (green), and Hoechst (blue) dye. White arrows indicate colocalization of LC3 with mitochondria. Over 100 cells from 6 random fields per experimental group, each in triplicate, were analyzed using ImageJ. Scale bar: 10 mm. (F) Mitophagy assessment in Pink1 +/+ and Pink1 -/-F4/80 + renal macrophages from mice fed with control (Ctl, n = 5 per group) or adenine (AD, n = 7 per group) diet for 28 days and stained with MitoTracker and LysoTracker dyes using flow cytometry. (G) Mitophagy assessment in Pink1 +/+ and Pink1 -/-BMDMs (n = 3 per group) cultured in the absence or presence of TGF-β1 (5 ng/mL) for 48 hours using flow cytometry. (H) Representative histograms for the detection of mitophagy showing the lyso dye-labeled positive lysosomes gated for Mtphagy dye-stained mitochondria. Data are mean ± SEM representative of 3 independent experiments and analyzed by Student's unpaired 2-tailed t test (A, B, and C) or 1-way ANOVA (E, F, and G). *P < 0.05. **P < 0.01, ***P < 0.001. lower expression of mitophagy regulatory proteins in patients with severe kidney disease provide evidence that mitophagy in mononuclear cells decreased with the progression of CKD.
Mitophagy controls human primary renal macrophage-induced fibrotic response. We next isolated the macrophages from human kidney (Supplemental Figure 4B ) and investigated the effects of TGF-β1 on the expression of mitophagy regulators. TGF-β1 treatment of human primary renal macrophages resulted in decreased expression of PINK1, MFN2, and Parkin, along with an increase in the fibrotic response, as assessed by FN and CX3CR1 expression ( Figure 8H ). In line with our above findings, these data suggest that increased fibrotic response by renal macrophages is associated with decreased expression of mitophagy regulators.
We next determined the effect of mitochondrial division inhibitor 1 (Mdivi1), a mitophagy inhibitor that has also been shown to modulate mROS production through mitochondrial complex I (36) . We observed that Mdivi1-treated human renal macrophages showed reduced expression of mitophagy mediators (PINK1, MFN2, and Parkin) ( Figure 8I ) and lower mitochondrial membrane potential than DMSO-treated (vehicle) cells ( Figure 8J ). The decrease in the expression of mitophagy mediators was associated with increased expression of TGF-β1, CD206, CX3CR1, FN, and α-SMA ( Figure 8I ).
Discussion
Mitophagy is found to be induced during acute kidney injury (14, 22, 37, 38) and compromised during CKD in animal models (39, 40) . Mitochondrial dysfunction is also reported in human kidney disease (33) . However, the role of macrophage mitophagy in the pathogenesis of kidney fibrosis in progressive CKD is largely unknown. Our findings utilizing 2 different models of kidney fibrosis indicate that the renal expression of mitophagy mediators is downregulated during kidney fibrosis and implicate the relevance in the development of kidney fibrosis. The present study provides the first demonstration to our knowledge that macrophage mitophagy is protective against kidney fibrosis via the PINK1/MFN2/ Parkin-mediated pathway.
The paradigm that mitophagy protects against kidney fibrosis by modulating the macrophage-derived fibrotic response is in accordance with evidence provided by previous reports. For example, autophagy regulates the macrophage-derived mitochondrial superoxide production, as both Beclin-1-or LC3-deficient macrophages produce higher superoxide anion radicals (O 2 -) (41) . Chemical inhibition of autophagy in macrophages using 3-methyladenine results in increased numbers of damaged mitochondria and the production of mROS (42) . In addition, the increase in the ROS levels is associated with enhanced differentiation of alternatively activated/M2 macrophages (43) . In the mouse model of diabetic nephropathy, mitochondrial-targeted antioxidant (MitoQ), by scavenging mROS, has been shown to protect against high glucose-induced renal damage and mitochondrial dysfunction (40) .
Our conclusion that PINK1-mediated mitophagy modulates macrophage-derived fibrotic response is supported by several compelling observations. First, we show that the renal macrophages from fibrotic kidneys of both Pink1 -/or Prkn -/mice display the amplified fibrotic response. Macrophage-specific deletion of Mfn2 aggravates kidney fibrosis. Second, the circulating and renal Ly6C lo CD11b + monocytes and renal profibrotic/M2 macrophages are higher, while the Ly6C hi proinflammatory and Ly6C int monocytes are lower during kidney fibrosis in Pink1 -/or Prkn -/or LysM-Cre +/− Mfn2 fl/fl mice. Ly6C lo monocytes and profibrotic macrophages contribute to advancing kidney fibrosis (4, 7, 25, 27) , while the Ly6C int population plays reparative functions during kidney injury (25) . Third, both Pink1 -/or Prkn -/renal macrophages show higher expression of Gal-3, a M2/profibrotic marker during kidney fibrosis. Fourth, both Pink1 -/or Prkn -/-BMDMs exhibit enhanced IL-4-induced polarization toward M2 phenotype in the presence of macrophage-CSF (M-CSF) conditioned media. The mechanism through which these mitophagy mediators regulate the macrophage-polarization toward M2 phenotype may be rictor dependent. Loss of Pink1 in BMDMs results in greater mitochondrial-derived superoxide production after TGF-β1 treatment. Previous studies have identified critical roles of rictor (28, 29, 44) and mitochondrial-derived ROS (43) in promoting macrophage differentiation toward M2 phenotype. Mitophagy is also demonstrated to regulate the expression of TGF-β1 mRNA in alveolar macrophages (45) . However, no study has investigated the role of PINK1-mediated mitophagy in macrophage reprogramming, particularly in the context of kidney fibrosis.
The reduced expression of mitophagy regulators in both the renal macrophages from the fibrotic kidney and the mitochondrial fractions from TGF-β1-treated BMDMs suggest that macrophage mitophagy is compromised during kidney fibrosis. We demonstrate that the numbers of abnormal mitochondria in Table 1 
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Non-CKD (n = 9) CKD (n = 6) P value Pink1 -/renal macrophages are increased in kidney fibrosis induced after 28 days of AD, suggesting the role of PINK1-mediated mitophagy in macrophage mitochondrial quality control. We show that, after AD-induced kidney fibrosis and in response to TGF-β1, mitophagy in renal macrophages and BMDMs respectively decreases. The loss of Pink1 was associated with reduced mitophagy in macrophages. Our data also show that the expression of mitophagy regulatory proteins in the mitochondria of BMDMs decreases after TGF-β1 treatment. The decline in OCR, ATP production, and maximal respiration by BMDMs in response to TGF-β1 treatment further confirms that macrophage-mitochondrial respiration is impacted during fibrotic conditions. Our findings confirm that PINK1 exerts critical function in maintaining macrophage-mitochondrial homeostasis. Accordingly, TGF-β1-treated Pink1 -/-BMDMs display lower mitochondrial respiration and higher mitochondrial-derived superoxide production. The mitophagy and mitochondrial respiration are highly interconnected processes. The damaged mitochondria with decreasing membrane potential are usually removed through mitophagy (15) . Accumulation of dysfunctional mitochondria due to defective mitophagy in the absence of PINK1 exaggerates mitochondrialderived oxidative stress that may negatively regulate mitochondrial respiration. The understanding of the molecular regulation of mitophagy in macrophages is not well established. We show that PINK1 functions upstream of MFN2, as the phosphorylation of MFN2 at Ser-442 decreases after PINK1-knockdown in human macrophages. Our observations indicate that the MFN2 bridges between PINK1 and Parkin and facilitates the import of cytosolic Parkin to the depolarized mitochondria, as evidenced by LysM-Cre +/− Mfn2 fl/fl BMDMs displaying significantly lower mitophagy with or without TGF-β1 treatment. Moreover, the FCCP-induced recruitment of Parkin on the depolarized mitochondria was lower in the absence of MFN2. These findings suggest that the mitophagy in macrophages involves MFN2-dependent recruitment of cytosolic Parkin to the damaged mitochondria. Our findings on the molecular regulation of mitophagy in macrophages support the published studies on the mechanism of mitophagy in other cells (20, 46) . However, TGF-β1-induced decrease in the recruitment of mitophagy regulatory proteins on the mitochondria of macrophages has not been described before, to our knowledge.
Our findings in human primary renal macrophages and CKD patients strongly corroborate our experimental observations from animal models. Our studies confirm that the mitophagy in the kidney and mononuclear cells was impaired, while the circulating levels of chemokine CCL2, which promotes macrophage recruitment into the kidney, was higher in patients with severe CKD. These findings on macrophages and mitophagy are in line with the earlier published studies performed in animal models (2, 4, 22, 39, 40) and collectively highlight the cytoprotective role of mitophagy against macrophage-derived progression of kidney fibrosis.
Our investigations using primary human renal macrophages also confirm that PINK1/Parkin-mediated mitophagy regulates macrophage-induced fibrotic response. This is based on our findings that (a) the expression of downstream regulators of PINK1-dependent mitophagy decreases after a TGF-β1-induced increase in the fibrotic response and (b) the increase in the expression of fibrotic markers in Mdivi1-treated macrophages is associated with a decrease in the expression of mitophagy regulators. However, further research is required to determine the PINK1/Parkin-dependent mechanism of regulation of macrophage polarization toward M2 phenotype through mROS or rictor.
In conclusion, our present studies provide a mechanistic understanding of the role of PINK1/ MFN2/Parkin-mediated macrophage mitophagy and its role in the context of kidney fibrosis. Our findings indicate that the mitophagy regulators are downregulated in experimental animal models of kidney fibrosis, in renal macrophages from fibrotic kidney, in TGF-β1-treated primary mouse BMDMs and human renal macrophages, and in the human CKD kidney. The deficiency of mitophagy regulators contributes to mitochondrial dysfunction, impaired mitophagy, and elevated levels of mROS and rictor expression, both of which promote macrophage reprogramming toward profibrotic/M2 phenotype ( Figure 9 ). Therefore, it may be prudent to investigate the potential of therapeutically targeting (47) . Briefly, mice (3-5 per group) were anesthetized, and ureteral obstruction surgery was carried out by double ligation of the left ureter using 4-0 silk suture via a left flank incision. Sham-operated mice had their ureters exposed but not ligated. The kidneys were harvested on day 7 for histology, Western blotting, and flow cytometry. The blood was collected for flow cytometry. AD-induced model of kidney fibrosis. Mice were fed with 0.2% of AD or control diet (Envigo; TD150071) as previously described (48) . The kidneys were collected at the end of the study on day 14 or day 28 for Western blotting, hydroxyproline assay, and electron microscopy. Whole blood samples were collected for chemokine analysis.
Cell culture and transfection. For the isolation of BMDMs, BM cell suspension was prepared through flushing femurs and tibias, and it was cultured in the presence of M-CSF (10 ng/mL; BioLegend) for 7 days (49) . The polarization of BMDMs toward M1 macrophages was performed using recombinant IFN-γ (rIFN-γ; 10 ng/mL; BioLegend), LPS (100 ng/mL; Invivogen), and granulocyte M-CSF (GM-CSF; 25 ng/mL; Stemcell Technologies). For M2 macrophages, BMDMs were cultured in the presence of rIL-4 (10 ng/mL; BioLegend) and M-CSF (25 ng/mL; BioLegend) for 24 hours. . Proposed mechanism of regulation of macrophage-derived fibrotic response by mitophagy. Kidney injury by suppressing the expression of mitophagy regulators (PINK1, MFN2, and Parkin) contributes to mitochondrial dysfunction in renal macrophages. The deficiency of PINK1 causes a reduction in the mitofusin-2 (MFN2) phosphorylation at Serine-442. The loss of MFN2 results in lower recruitment of Parkin to the mitochondria and defective mitophagy in macrophages. The failure of mitophagy causes accumulation of abnormal mitochondria, increase in mROS production, and expression of rictor in macrophages. mROS and rictor both promote the differentiation of macrophages toward profibrotic/M2 phenotype. The increase in the frequency of profibrotic/M2 macrophages results in higher extracellular matrix (ECM) production and progression of kidney fibrosis.
Peritoneal macrophages were isolated by recovering peritoneal lavage (49) , allowed to adhere to the sterile petri dishes for 3 hours, and subsequently subjected to treatment with FCCP (5 μM/mL; Abcam) or DMSO (vehicle control) for 2 hours.
The macrophages from a human monocytic THP-1 cell line (ATCC TIB-202) were derived by incubating in the presence of phorbol 12-myristate 13-acetate (PMA; 10 ng/mL; MilliporeSigma) for 3 days. Human SMARTpool on-target plus Pink1-specific (L-004030-00-0005) or nontargeting (D-001810-10-05) siRNAs were purchased from Dharmacon (GE Healthcare). THP-1-derived macrophages were transfected with a pool of either Pink1-specific or nontargeting siRNAs using transfection reagent (Lipofectamine RNAimax; Thermo Fisher Scientific) followed by treatment with TGF-β1 (5 ng/mL; R&D Systems) for 24 hours.
Isolation of renal macrophages. The macrophages from mouse and human kidneys were isolated using Ficoll-Hypaque (Thermo Fisher Scientific) density gradient centrifugation followed by magnetic-activated cell sorting (MACS) separation protocol (Supplemental Figure 4) . Kidney tissue was minced into 1-2 mm 3 pieces and digested using collagenase type I (2 mg/mL; Thermo Fisher Scientific). The single-cell suspensions obtained after digestion were subsequently incubated with ACK lysing buffer (Thermo Fisher Scientific) for the lysis of RBCs, followed by isolation of renal mononuclear cells (RMNCs) by Ficoll-Hypaque density gradient centrifugation method (50) . The macrophages from mouse RMNCs were sorted using anti-CD115 biotin-conjugated antibody and anti-biotin microbeads (Miltenyi Biotec) using MACS cell separation protocol for CD115 positive selection (Supplemental Figure 4A and ref. 28 ). The macrophages from human RMNCs were sorted using PE-conjugated anti-CD68 antibody and anti-PE ultrapure microbeads (Miltenyi Biotec) using MACS positive cell selection protocol (Supplemental Figure 4B) .
PBMC isolation. PBMCs were isolated from whole blood using the Ficoll-Paque (GE Healthcare) density gradient centrifugation method as previously described (50) . Blood samples were first diluted in PBS in 1:1 and layered on the surface of Ficoll-Paque and centrifuged at 670 g for 20 minutes at 20°C with no breaks. The mononuclear cells were carefully harvested from the interface of diluted plasma and Ficoll. RBCs were lysed using ACK lysing buffer (Thermo Fisher Scientific). Cells were washed and stored in cryopreservation media containing 50% FBS (Invitrogen) and 10% DMSO (Sigma-Aldrich) in RPMI (Thermo Fisher Scientific).
Flow cytometry. The surface and intracellular staining were performed on renal single-cell suspensions, BMDMs, or peritoneal macrophages. The nonspecific sites were blocked by using anti-CD16 and anti-CD32 antibodies (BioLegend, 101302) by incubating cells for 15 minutes at 4°C. The following antibodies were used for staining: anti-CD45 (BioLegend, clone 30-F11); anti-F4/80 (clone BM8), anti-CD11b (clone M1/70), anti-CD206 (clone MR6F3), and anti-Ly6C (clone HK1.4) (Thermo Fisher Scientific); anti-Gal-3 (BioLegend, clone M3/38); anti-latency associated peptide (LAP or TGF-β1) (BioLegend, clone TW7-16B4); anti-MFN2 (Abcam, clone 6A8); and anti-Parkin (Cell Signaling Technology, catalog 3132S) antibodies. The fixation permeabilization treatment was performed before staining for an intracellular marker using fix/perm buffer (Thermo Fisher Scientific) for 15 minutes at 4°C. The secondary fluorochrome-conjugated antibodies used were anti-rabbit Alexa Fluor 488 and anti-mouse Alexa Fluor 647 (Thermo Fisher Scientific; catalogs A-11001 and A-21244, respectively). The stained cells were washed twice with FACS buffer (PBS with 2% FBS; Invitrogen) and fixed using 2% paraformaldehyde (Santa Cruz Biotechnology Inc.). The cells were captured using BD Accuri C6 flow cytometer, and the data were analyzed using C6 analysis (BD Biosciences) or FlowJo version 10.8 (Tree Star Inc.) software.
Measurement of mitophagy, membrane potential, and superoxide levels by flow cytometry. The mitophagy in renal single-cell suspensions was determined through flow cytometry staining for MitoTracker and LysoTracker dyes and anti-F4/80 antibody (Thermo Fisher Scientific, clone BM8) as per the manufacturer's protocol. The mitophagy in BMDMs was detected according to the assay protocol (mitophagy detection kit, Dojindo) using flow cytometry (51, 52) . BMDMs were incubated with Mtphagy dye (100 nmol/L) at 37°C for 1 hour with 5% CO 2 and 95% humidity, followed by treatment with TGF-β1 (5 ng/ mL) for 48 hours at 37°C in serum-free M-CSF (BioLegend) conditioned media. The cells were then washed and incubated with Lyso dye (1 μmol/L) for 1 hour. The mean fluorescence intensity (MFI) or the counts of the double-positive signal for the Mtphagy dye-stained mitochondria colocalized with Lyso dye-labeled lysosomes were measured using flow cytometry (Accuri C6, BD Biosciences).
